Martin Shkreli violated lifetime pharma industry ban, FTC and states say in contempt claim
Shkreli was banned from the pharmaceutical industry after a trial found that he organized an illegal scheme to perpetuate a monopoly for the drug Daraprim.
В этом разделе статьи показаны на английском.
Martin Shkreli violated lifetime pharma industry ban, FTC and states say in contempt claim
Редакция Trade News (2026-10-13) фиксирует рынок: Shkreli was banned from the pharmaceutical industry after a trial found that he organized an illegal scheme to perpetuate a monopoly for the drug Daraprim. Первоисточник — оригинал CNBC Top News (cnbc.com).
Читайте также
‘Breaking Bad’ star Aaron Paul sells L.A. home for $7.5 million; he now lives in Paris
Who should pay for a birthday dinner? I always treat my guests.
UnitedHealth keeps medical costs under control — and raises its outlook again
